PRVB +21% on SNY co-marketing deal: https://www.prnewswire.com/news-releases/provention-bio-to-combine-forces-with-sanofi-to-support-potential-us-launch-of-teplizumab-for-delay-in-onset-of-clinical-type-1-diabetes-t1d-in-at-risk-individuals-301642021.html